Cargando…
Should Neoadjuvant Treatment Be Adopted More Widely for Patients With Extremity Soft Tissue Sarcoma in Low-Income Countries?
Autor principal: | Mangla, Ankit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581658/ https://www.ncbi.nlm.nih.gov/pubmed/37441745 http://dx.doi.org/10.1200/GO.23.00110 |
Ejemplares similares
-
Neoadjuvant Chemoradiation Herapy for Soft Tissue Sarcomas of the Extremities
por: Aguiar, Samuel, et al.
Publicado: (2009) -
Unplanned Excision of Soft Tissue Sarcomas of the Extremities in a Low-to-Middle-Income Country
por: Wang, Edward H. M., et al.
Publicado: (2023) -
Extremities Soft Tissue Sarcomas, more Common and as Dangerous as Bone Sarcomas
por: Voltan, Karen, et al.
Publicado: (2021) -
Neoadjuvant Chemoradiation Compared With Neoadjuvant Radiation Alone in the Management of High-Grade Soft Tissue Extremity Sarcomas
por: Hazell, Sarah Z., et al.
Publicado: (2019) -
Neoadjuvant Treatment Options in Soft Tissue Sarcomas
por: Spałek, Mateusz Jacek, et al.
Publicado: (2020)